3533.TW
Lotes Co., Ltd.
TaiwanTWDEQUITY
Technology
DELAYED
Last price
1,595.00
▼ 15.00 (0.93%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1,600.00
Prev close
1,610.00
Day high
1,640.00
Day low
1,585.00
Volume
1.19M
Market cap
$181.41B
P/E (TTM)
22.42
52W range
1,140.00 – 2,955.00
Day trading desk
Gap from prior close
-0.62%
Prior close 1,610.00
VWAP
1,605.48
-0.65% from price
Relative volume
0.94×
Normal
Session range
3.47%
1,585.00 – 1,640.00
Position in range
18%
Near session low
ATR (14D)
96.07
6.02% of price
Prior day high
1,645.00
PDH
Prior day low
1,570.00
PDL
Bid / ask spread
—
Quote not published
Session volume
1.07M
Avg 1.13M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-7.27%
-5.9%
1M
-21.62%
-25.4%
3M
-38.30%
-41.4%
6M
-1.85%
-12.9%
YTD
+23.17%
+10.9%
1Y
+6.69%
-13.3%
3Y
+96.91%
+22.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 3533.TW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
29.15M
Total on file
Fundamentals
Market cap$181.41B
Enterprise value$166.77B
Revenue (TTM)$36.58B
Gross profit$18.06B
EBITDA$12.98B
Net income$9.22B
EPS (TTM)$71.14
Free cash flow$-1.67B
Total cash$16.20B
Total debt$1.50B
Book value / share$364.42
Shares outstanding113.73M
Float83.24M
Short % of float—
Dividend yield2.19%
Beta (5Y)0.25
Valuation & profitability ratios
Trailing P/E22.42
Forward P/E13.67
PEG ratio—
Price / sales—
Price / book4.38
EV / revenue4.56
EV / EBITDA12.85
Gross margin49.37%
Operating margin21.98%
Profit margin25.21%
Return on equity24.44%
Return on assets11.94%
Debt / equity3.49
Current ratio2.77
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $33.78B | $30.09B | $24.48B | $961.41M | — | +12.3% |
| Operating revenue | $33.78B | $30.09B | $24.48B | $961.41M | — | +12.3% |
| Cost of revenue | $16.45B | $14.32B | $13.00B | $807.84M | — | +14.9% |
| Gross profit | $17.33B | $15.77B | $11.48B | $153.57M | — | +9.9% |
| Research & development | $3.50B | $2.73B | $2.17B | $26.61M | — | +28.3% |
| Selling, general & admin | $3.49B | $2.79B | $2.37B | $127.49M | — | +24.8% |
| Total operating expense | $6.99B | $5.52B | $4.55B | $154.10M | — | +26.5% |
| Operating income | $10.34B | $10.25B | $6.93B | -$530.00K | — | +1.0% |
| Net interest income | $304.72M | $470.89M | $254.41M | $1.68M | — | -35.3% |
| Pre-tax income | $10.19B | $11.87B | $7.52B | $82.37M | — | -14.1% |
| Tax provision | $2.24B | $2.49B | $1.79B | $22.35M | — | -9.8% |
| Net income | $7.87B | $9.28B | $5.59B | $55.57M | — | -15.2% |
| Net income to common | $7.87B | $9.28B | $5.59B | $55.57M | — | -15.2% |
| Basic EPS | — | 82.77 | 50.65 | 1.06 | 33.16 | — |
| Diluted EPS | — | 82.33 | 50.19 | 1.05 | 32.53 | — |
| EBIT | $10.26B | $11.96B | $7.59B | $88.00M | — | -14.2% |
| EBITDA | $12.87B | $14.23B | $9.98B | $158.26M | — | -9.6% |
| Basic shares | — | 112.08M | 110.42M | 106.54M | 104.71M | — |
| Diluted shares | — | 112.74M | 111.62M | 108.19M | 106.75M | — |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $12.50B | $18.66B | $13.13B | $316.84M | -33.0% |
| Cash & short-term investments | $13.62B | $18.85B | $13.19B | $536.05M | -27.8% |
| Accounts receivable | $13.30B | $11.95B | $9.31B | $358.36M | +11.4% |
| Inventory | $4.37B | $3.42B | $2.66B | $191.25M | +28.0% |
| Total current assets | $33.23B | $35.76B | $26.07B | $1.11B | -7.1% |
| Property, plant & equipment | $14.85B | $12.22B | $10.41B | $538.03M | +21.6% |
| Goodwill & intangibles | $302.18M | $217.36M | $150.11M | $4.58M | +39.0% |
| Total assets | $50.43B | $50.21B | $37.95B | $2.40B | +0.4% |
| Total current liabilities | $9.00B | $11.18B | $6.85B | $545.28M | -19.5% |
| Current debt | $233.75M | $3.77B | $1.59B | $289.64M | -93.8% |
| Long-term debt | $294.28M | $288.67M | $934.15M | $377.22M | +1.9% |
| Total debt | $1.04B | $4.61B | $3.14B | $687.49M | -77.4% |
| Total liabilities | $10.02B | $12.25B | $8.57B | $971.86M | -18.2% |
| Retained earnings | $24.17B | $21.04B | $15.67B | $59.43M | +14.9% |
| Shareholder equity | $38.44B | $35.97B | $27.77B | $1.34B | +6.9% |
| Working capital | $24.23B | $24.58B | $19.22B | $564.87M | -1.4% |
| Net tangible assets | $38.14B | $35.75B | $27.62B | $1.33B | +6.7% |
| Shares issued | 112.53M | 112.53M | 111.33M | 107.40M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $10.19B | $11.87B | $7.52B | $82.37M | — | -14.1% |
| Depreciation & amortisation | $2.61B | $2.28B | $2.39B | $70.25M | — | +14.5% |
| Stock-based compensation | $44.44M | $25.65M | $58.06M | $10.82M | — | +73.3% |
| Change in working capital | -$1.86B | -$1.94B | $1.22B | -$12.40M | — | +4.0% |
| Operating cash flow | $8.53B | $10.06B | $9.13B | $134.39M | — | -15.2% |
| Capital expenditure | -$5.10B | -$3.88B | -$2.70B | -$45.10M | — | -31.6% |
| Investing cash flow | -$5.86B | -$4.69B | -$2.77B | -$450.17M | — | -25.0% |
| Share buybacks | -$676.15M | $0 | — | $0 | $0 | — |
| Dividends paid | -$4.67B | -$2.90B | -$2.80B | -$10.12M | — | -61.1% |
| Financing cash flow | -$8.84B | -$321.88M | -$295.61M | $303.65M | — | -2,647.8% |
| Free cash flow | $3.43B | $6.18B | $6.44B | $89.29M | — | -44.5% |
| End cash position | $12.50B | $18.66B | $13.13B | $316.84M | — | -33.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $9.33B | $9.26B | $8.42B | $8.34B | $7.77B | +0.7% |
| Operating revenue | $9.33B | $9.26B | $8.42B | $8.34B | $7.77B | +0.7% |
| Cost of revenue | $4.71B | $4.49B | $4.11B | $4.09B | $3.77B | +4.9% |
| Gross profit | $4.62B | $4.77B | $4.31B | $4.25B | $4.00B | -3.2% |
| Research & development | $975.14M | $986.98M | $889.24M | $842.80M | $783.99M | -1.2% |
| Selling, general & admin | $938.09M | $1.02B | $900.01M | $804.64M | $764.36M | -7.8% |
| Total operating expense | $1.91B | $2.00B | $1.79B | $1.65B | $1.55B | -4.5% |
| Operating income | $2.71B | $2.77B | $2.52B | $2.60B | $2.45B | -2.2% |
| Net interest income | $47.69M | $47.81M | $53.71M | $93.24M | $109.96M | -0.3% |
| Pre-tax income | $3.00B | $3.22B | $2.88B | $1.22B | $2.87B | -6.7% |
| Tax provision | $571.89M | $649.11M | $565.42M | $456.51M | $572.78M | -11.9% |
| Net income | $2.40B | $2.52B | $2.32B | $749.04M | $2.28B | -5.0% |
| Net income to common | $2.40B | $2.52B | $2.32B | $749.04M | $2.28B | -5.0% |
| Basic EPS | 21.37 | — | 20.71 | 6.69 | 20.22 | — |
| Diluted EPS | 21.34 | — | 20.69 | 6.68 | 20.20 | — |
| EBIT | $3.02B | $3.23B | $2.90B | $1.23B | $2.89B | -6.7% |
| EBITDA | $3.84B | $3.96B | $3.56B | $1.84B | $3.51B | -3.1% |
| Basic shares | 112.16M | — | 111.94M | 111.96M | 112.55M | — |
| Diluted shares | 112.28M | — | 112.05M | 112.13M | 112.66M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.27B | $12.50B | $13.01B | $16.68B | $19.71B | +6.1% |
| Cash & short-term investments | $14.54B | $13.62B | $13.70B | $16.88B | $19.91B | +6.8% |
| Accounts receivable | $13.77B | $13.30B | $12.15B | $11.13B | $11.24B | +3.5% |
| Inventory | $5.23B | $4.37B | $3.71B | $3.42B | $3.53B | +19.5% |
| Total current assets | $36.01B | $33.23B | $31.29B | $32.92B | $36.30B | +8.3% |
| Property, plant & equipment | $16.01B | $14.85B | $13.24B | $12.34B | $13.12B | +7.8% |
| Goodwill & intangibles | $312.25M | $302.18M | $252.76M | $216.47M | $207.63M | +3.3% |
| Total assets | $54.37B | $50.43B | $46.91B | $47.71B | $51.48B | +7.8% |
| Total current liabilities | $9.45B | $9.00B | $9.72B | $13.84B | $9.69B | +4.9% |
| Current debt | $253.10M | $233.75M | $1.57B | $835.95M | $2.30B | +8.3% |
| Long-term debt | $0 | $294.28M | $292.86M | $291.46M | $290.06M | -100.0% |
| Total debt | $942.50M | $1.04B | $2.35B | $1.62B | $3.14B | -9.6% |
| Total liabilities | $10.36B | $10.02B | $10.66B | $14.79B | $10.76B | +3.4% |
| Retained earnings | $26.57B | $24.17B | $21.65B | $19.34B | $23.32B | +9.9% |
| Shareholder equity | $41.93B | $38.44B | $34.38B | $31.09B | $38.70B | +9.1% |
| Working capital | $26.56B | $24.23B | $21.57B | $19.08B | $26.61B | +9.6% |
| Net tangible assets | $41.62B | $38.14B | $34.13B | $30.87B | $38.49B | +9.1% |
| Shares issued | 112.53M | 112.53M | 112.53M | 112.53M | 112.84M | 0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $3.00B | $3.22B | $2.88B | $1.22B | $2.87B | — | -6.7% |
| Depreciation & amortisation | $827.76M | $732.75M | $656.60M | $604.89M | $615.87M | — | +13.0% |
| Stock-based compensation | $4.87M | $40.92M | $864.00K | $884.00K | $1.77M | — | -88.1% |
| Change in working capital | -$1.42B | -$1.48B | -$1.17B | $640.11M | $153.06M | — | +4.3% |
| Operating cash flow | $2.13B | $1.47B | $1.33B | $2.29B | $3.44B | — | +44.4% |
| Capital expenditure | -$1.53B | -$1.36B | -$1.29B | -$1.14B | -$1.31B | — | -12.9% |
| Investing cash flow | -$1.59B | -$1.79B | -$1.57B | -$1.32B | -$1.17B | — | +11.5% |
| Share buybacks | — | $0 | $0 | — | — | — | — |
| Dividends paid | — | $0 | — | — | — | $0 | — |
| Financing cash flow | -$203.82M | -$1.04B | -$4.06B | -$2.23B | -$1.51B | — | +80.3% |
| Free cash flow | $593.26M | $115.00M | $41.49M | $1.15B | $2.12B | — | +415.9% |
| End cash position | $13.27B | $12.50B | $13.01B | $16.68B | $19.71B | — | +6.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 18.74 | 17.68 | -5.6% |
| Mar 2026 | 20.65 | 21.37 | +3.5% |
| Dec 2025 | 20.15 | 22.53 | +11.8% |
| Sep 2025 | 20.70 | 20.71 | +0.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 21.73 | 1 | $10.33B | +22.7% |
| Next quarter | 23.89 | 1 | $10.68B | +15.3% |
| Current year | 84.60 | 1 | $39.91B | +18.1% |
| Next year | 116.66 | 16 | $49.90B | +25.1% |
Analyst targets & ownership
Mean target$2,478.33
High target$3,200.00
Low target$1,670.00
Implied upside55.38%
Analyst count15
ConsensusBUY
Strong buy / Buy2 / 9
Hold4
Sell / Strong sell0 / 0
Held by insiders25.93%
Held by institutions48.80%
Institutions holding230
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1,764.00
-9.58% from price
SMA 20
1,827.50
-12.72% from price
SMA 50
1,992.00
-19.93% from price
SMA 100
2,230.95
-28.51% from price
SMA 200
1,851.10
-13.84% from price
EMA 12
1,742.63
-8.47% from price
EMA 26
1,848.04
-13.69% from price
EMA 50
1,964.18
-18.80% from price
RSI (14)
31.9
Neutral
MACD (12,26,9)
-105.41
Hist -26.56
ATR (14)
96.07
6.02% of price
Realised vol 30D
68.6%
Annualised
Bollinger upper
2,125.99
20, 2σ
Bollinger lower
1,529.01
20, 2σ
50 / 200 cross
Golden
1,992.00 vs 1,851.10
Trend bias
Below 200
-13.84%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.05
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
68.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-44.0%
Peak to trough
Max drawdown 5Y
-47.9%
Peak to trough
ATR 14
96.07
6.02% of price
Beta (reported)
0.25
5Y monthly, from filing
Dividends & splits
Forward rate$34.93 / yr
Forward yield2.19%
5-year avg yield2.10%
Payout ratio58.60%
Ex-dividend dateAug 4, 2026
Next pay date—
Last split105:100
Split dateJul 23, 2008
Headlines
Novotech Strengthens Presence in Japan with Opening of Tokyo Office
Business Wire · 6m ago
Dow Jones Futures: Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 12m ago
A Tax Strategy So Aggressive It Built the World’s Largest Hedge Fund and Made Losing Money the Hottest Product on Wall Street
24/7 Wall St. · 13m ago
Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?
Insider Monkey · 14m ago
The Cannabis M&A Wave Is Here. Curaleaf Proved It. Here's Whether Green Thumb Should Ride It -- or Wait to Be Swept Up.
Motley Fool · 17m ago
Prediction: Oklo Won't Book Its First Commercial Power Revenue Before 2028
Motley Fool · 21m ago
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 24m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.